image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 9 days, don't miss out!

SIGN UP NOW
Updates & Ideas

Kooth - Digital mental health services firm wins transformational US contract

May 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • KOO
  • Price:
  • 265p
According to an article in general medical journal, The Lancet, mental health disorders account for at least 18% of the global disease burden, and the associated annual costs are projected to be US$6 trillion by 2030. While evidence-based interventions do exist, only a small proportion of people, typically with the most acute symptoms, receive adequate treatment and waiting lists for CAMHS (NHS child and adolescent mental health services) can be more than a year. Against this backdrop shares in Kooth, the largest digital mental health provider for the NHS for children and young people aged 10-25, have doubled this year and over the month I met with its CEO, Tim Barker. If you look at Kooth’s forecasts (no profit is expected until ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Kooth - US$188m contract win (August 2023)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author